Repligen director granted RSUs and stock options
Repligen Corporation director Konstantin Konstantinov received new equity awards consisting of restricted stock units and stock options.
Rhea-AI Filing Summary
Repligen Corporation director Konstantin Konstantinov received new equity awards consisting of restricted stock units and stock options. He was granted 995 restricted stock units, each representing one share of Repligen common stock, bringing his direct common stock holdings to 3,889 shares after the award.
He was also granted stock options covering 2,239 shares of common stock at an exercise price of $103.38 per share, with the options expiring on May 14, 2036. Both the restricted stock units and the option award vest in full on the earlier of May 14, 2027, one year from the grant date, or the date of the next annual meeting of shareholders.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 3,234 shares
Grant/Award
2 txns
Insider
Konstantinov Konstantin
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 2,239 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 995 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 2,239 contracts (Direct);
Common Stock — 3,889 shares (Direct)
Footnotes (2)
- F1. Mr. Konstantinov was awarded 995 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The restricted stock units vest on the earlier of May 14, 2027, one year from the grant date, or the date of the next annual meeting of the Company's shareholders, which has not yet been determined. The restricted stock units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- F2. Award vests in full on the earlier of May 14, 2027, one year from grant date, or on the date of the next annual meeting of the Company's shareholders, which has not yet been determined.
Key Figures
RSUs granted: 995 units
Common shares held after grant: 3,889 shares
Options granted: 2,239 shares
+3 more
6 metrics
RSUs granted
995 units
Restricted stock units granted to director on May 14, 2026
Common shares held after grant
3,889 shares
Director’s direct common stock holdings following RSU award
Options granted
2,239 shares
Stock option award covering Repligen common stock
Option exercise price
$103.38 per share
Exercise price for 2,239 stock options
Option expiration
May 14, 2036
Expiration date of granted stock options
Vesting date trigger
May 14, 2027 or next annual meeting
Vesting schedule for RSUs and options
Key Terms
restricted stock units, Stock Option (Right to Buy, exercise price, vest in full, +1 more
5 terms
restricted stock units financial
"Mr. Konstantinov was awarded 995 restricted stock units."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Stock Option (Right to Buy financial
"security_title: Stock Option (Right to Buy)"
exercise price financial
"conversion_or_exercise_price: "103.3800""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest in full financial
"Award vests in full on the earlier of May 14, 2027"
FAQ
What did Repligen (RGEN) director Konstantin Konstantinov receive in this Form 4 filing?
Konstantin Konstantinov received equity compensation consisting of 995 restricted stock units and stock options on 2,239 shares. These awards increase his direct equity exposure to Repligen and are structured to vest based on time and the next annual shareholder meeting.
What are the terms of the Repligen (RGEN) stock options granted to Konstantin Konstantinov?
Konstantin Konstantinov received stock options on 2,239 Repligen shares at an exercise price of $103.38 per share. These options vest in full on the earlier of May 14, 2027, one year from grant, or the next annual shareholder meeting, and expire on May 14, 2036.
How do the restricted stock units for Repligen (RGEN) vest for Konstantin Konstantinov?
The 995 restricted stock units vest in full on the earlier of May 14, 2027, one year from the grant date, or the date of Repligen’s next annual shareholder meeting. Each unit settles into one share of common stock upon vesting, delivered in shares only.
Are the new Repligen (RGEN) equity awards to Konstantin Konstantinov open-market purchases or compensation grants?
The awards are compensation-related grants, not open-market purchases. Both the 995 restricted stock units and the 2,239 stock options are reported with transaction code A, indicating grants or awards given at no cash cost per share in this Form 4 filing.
AI-generated analysis. How Rhea-AI works. Not financial advice.
